In the last trading session, 1.48 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 1.72. With the company’s per share price at $46.91 changed hands at -$0.28 or -0.59% during last session, the market valuation stood at $345.13M. TNXP’s last price was a discount, traded about -177.13% off its 52-week high of $130.00. The share price had its 52-week low at $6.76, which suggests the last value was 85.59% up since then. When we look at Tonix Pharmaceuticals Holding Corp’s average trading volume, we note the 10-day average is 1.1 million shares, with the 3-month average coming to 960.03K.
Analysts gave the Tonix Pharmaceuticals Holding Corp (TNXP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TNXP as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Instantly TNXP was in red as seen at the end of in last trading. With action 14.78%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -23.20%, with the 5-day performance at 14.78% in the green. However, in the 30-day time frame, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is 34.34% up. Looking at the short shares, we see there were 1.13 million shares sold at short interest cover period of 0.85 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 73.03%. The 2025 estimates are for Tonix Pharmaceuticals Holding Corp earnings to increase by 93.08%, but the outlook for the next 5-year period is at 88.07% per year.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next quarterly earnings report on 2025-May-12.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.05% of Tonix Pharmaceuticals Holding Corp shares while 7.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.04%. There are 7.03% institutions holding the Tonix Pharmaceuticals Holding Corp stock share, with PRUDENTIAL FINANCIAL INC the top institutional holder. As of 2024-06-30, the company held 0.0239% of the shares, roughly 97707.0 TNXP shares worth $68141.0.
ALYESKA INVESTMENT GROUP, L.P. holds the second largest percentage of outstanding shares, with 0.0153% or 62500.0 shares worth $43588.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 88.86 shares estimated at $4.17 million under it, the former controlled 1.21% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.42% of the shares, roughly 30.61 shares worth around $1.44 million.
